Scanis signs Mammex marketing deal with Trex:
This article was originally published in Clinica
Executive Summary
Scanis, of Foster City, California, which is developing the Mammex TR computer system for assisting radiologists in the detection of breast cancer, has signed a strategic alliance agreement with Trex Medical. Mammex workstations will be offered as an accessory to the Trex Digital Mammography System, currently pending 510(k) FDA approval, through Trex Medical's worldwide distribution system of 180 dealers and 1,000 sales representatives.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.